每經(jing)AI快訊，12月15日，邁(mai)威生物公(gong)(gong)(gong)告，為滿足公(gong)(gong)(gong)司經(jing)營發展的(de)資(zi)金需(xu)求，實現公(gong)(gong)(gong)司可持續發展，提升公(gong)(gong)(gong)司國際化水平，根據(ju)相關法(fa)律、法(fa)規的(de)要求，公(gong)(gong)(gong)司擬在(zai)境外發行股(gu)(gu)(gu)份(H股(gu)(gu)(gu))并在(zai)香港聯交所主板(ban)上(shang)市(shi)(簡稱“本(ben)次發行H股(gu)(gu)(gu)并上(shang)市(shi)”)，公(gong)(gong)(gong)司將在(zai)股(gu)(gu)(gu)東大(da)會決議有效期內選擇適當(dang)的(de)時機和發行窗口完(wan)成(cheng)本(ben)次發行H股(gu)(gu)(gu)并上(shang)市(shi)。